In a regulatory filing, Allergan states: “Allergan’s highly engaged, refreshed and independent Board of Directors is focused on doing what is in the best interests of all shareholders. We believe Appaloosa, who owns less than 1% stake, is attempting to undermine our CEO and pushing for a firesale of the company for a short-term bump in stock price. We believe that it will be transparent to investors that Appaloosa’s short-term interests are not the same as those of long-term shareholders.”
https://thefly.com/landingPageNews.php?id=2883999
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.